Endocyte, Inc. (ECYT) Selects Medidata Solutions, Inc. Clinical Cloud to Support Oncology Studies
12/14/2012 10:21:27 AM
NEW YORK--(BUSINESS WIRE)--Biopharmaceutical company Endocyte has selected the Medidata Solutions (NASDAQ: MDSO) cloud-based platform to support the execution of multiple ongoing clinical trials focused on the development of targeted therapies for cancer and other serious diseases. Endocyte has a rich pipeline of drugs in clinical development, including proprietary technology for ovarian and lung cancer indications. The company recently filed for commercial authorization in the European Union (EU) for one treatment aimed at addressing a form of ovarian cancer. Endocyte is implementing the combined solution of Medidata’s electronic data capture (EDC) and clinical data management (CDM) system Medidata Rave® along with Medidata CTMS™.